173 filings
Page 3 of 9
6-K
2mc20gulhm1 s7s4d
16 Dec 22
Aptorum Group Announces Completion of $3 Million Convertible Note due 2023
8:00am
UPLOAD
6fun98
15 Dec 22
Letter from SEC
12:00am
6-K
kut0b 6ris4ho2ptg
9 Dec 22
Aptorum Group Announces Offering of $3 Million Convertible Note due 2023
7:00am
CORRESP
idztt rsfmv5a
2 Dec 22
Correspondence with SEC
12:00am
UPLOAD
levmryrd7m1
22 Nov 22
Letter from SEC
12:00am
6-K
uwjp5z
18 Nov 22
Aptorum Group Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency
5:15pm
6-K
fsm xiplte613
8 Nov 22
Report of Foreign Private Issuer
6:00am
6-K
wu2dw dkakz27o2
30 Sep 22
Report of Foreign Private Issuer
4:01pm
6-K
zliptzsdwelpv
15 Sep 22
Aptorum Group Updates on the Clinical Validation of RPIDD Infectious Disease Liquid Biopsy Molecular Diagnostics
8:37am
6-K
1t60qlx
11 Jul 22
Report of Foreign Private Issuer
4:30pm
6-K
hrj8cytduo6liu10n
9 Jun 22
Current Report
4:08pm
EFFECT
bnab57
7 Jun 22
Notice of effectiveness
12:15am
POS AM
a5k99agclb668 350oc
1 Jun 22
Prospectus update (post-effective amendment)
4:30pm
6-K
144k9
31 May 22
Report of Foreign Private Issuer
4:03pm
6-K
fjrhbkqh202smnats76
29 Apr 22
Aptorum Group Limited Reports 2021 Fiscal Year End Financial Results and Provides Business Update
4:01pm
6-K
ob2x82zr8wj2 5fofrqs
10 Jan 22
Report of Foreign Private Issuer
8:02am
6-K
w8x 0scz8314q
3 Dec 21
Aptorum Group Limited Announces Results of 2021 Annual General Meeting of Shareholders
8:00am
6-K
uea l357wem1650guw88
17 Nov 21
Report of Foreign Private Issuer
4:01pm
6-K
m5temu0 06ji6qi167c
19 Oct 21
Report of Foreign Private Issuer
8:00am